Clinical Trials Browser

Phase 2 × Glioma × nilotinib × Clear all

NCT01140568 2020-05-05

Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas

Phase 2 Completed

38 enrolled 8 charts

Glioma